JPWO2022149578A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022149578A5
JPWO2022149578A5 JP2022539057A JP2022539057A JPWO2022149578A5 JP WO2022149578 A5 JPWO2022149578 A5 JP WO2022149578A5 JP 2022539057 A JP2022539057 A JP 2022539057A JP 2022539057 A JP2022539057 A JP 2022539057A JP WO2022149578 A5 JPWO2022149578 A5 JP WO2022149578A5
Authority
JP
Japan
Prior art keywords
solution
producing
solid
iii
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022539057A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022149578A1 (https=
JP7154465B1 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/000116 external-priority patent/WO2022149578A1/ja
Publication of JPWO2022149578A1 publication Critical patent/JPWO2022149578A1/ja
Priority to JP2022160447A priority Critical patent/JP7846599B2/ja
Application granted granted Critical
Publication of JP7154465B1 publication Critical patent/JP7154465B1/ja
Publication of JPWO2022149578A5 publication Critical patent/JPWO2022149578A5/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022539057A 2021-01-08 2022-01-05 Ac-225溶液の製造方法およびAc-225溶液を用いた医薬の製造方法 Active JP7154465B1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022160447A JP7846599B2 (ja) 2021-01-08 2022-10-04 Ac-225溶液の製造方法およびAc-225溶液を用いた医薬の製造方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021002437 2021-01-08
JP2021002437 2021-01-08
PCT/JP2022/000116 WO2022149578A1 (ja) 2021-01-08 2022-01-05 Ac-225溶液の製造方法およびAc-225溶液を用いた医薬の製造方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022160447A Division JP7846599B2 (ja) 2021-01-08 2022-10-04 Ac-225溶液の製造方法およびAc-225溶液を用いた医薬の製造方法

Publications (3)

Publication Number Publication Date
JPWO2022149578A1 JPWO2022149578A1 (https=) 2022-07-14
JP7154465B1 JP7154465B1 (ja) 2022-10-17
JPWO2022149578A5 true JPWO2022149578A5 (https=) 2022-12-14

Family

ID=82357768

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022539057A Active JP7154465B1 (ja) 2021-01-08 2022-01-05 Ac-225溶液の製造方法およびAc-225溶液を用いた医薬の製造方法
JP2022160447A Active JP7846599B2 (ja) 2021-01-08 2022-10-04 Ac-225溶液の製造方法およびAc-225溶液を用いた医薬の製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022160447A Active JP7846599B2 (ja) 2021-01-08 2022-10-04 Ac-225溶液の製造方法およびAc-225溶液を用いた医薬の製造方法

Country Status (10)

Country Link
US (2) US11752223B2 (https=)
EP (1) EP4276855A4 (https=)
JP (2) JP7154465B1 (https=)
KR (2) KR102500942B1 (https=)
CN (1) CN116711028A (https=)
AU (1) AU2022206140A1 (https=)
CA (1) CA3207700A1 (https=)
TW (1) TW202235093A (https=)
WO (1) WO2022149578A1 (https=)
ZA (1) ZA202306906B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202233247A (zh) * 2020-10-16 2022-09-01 日商日本醫事物理股份有限公司 抗her2抗體之放射性複合體及放射性醫藥
WO2026063503A1 (ja) * 2024-09-20 2026-03-26 日本メジフィジックス株式会社 Ac-225溶液の製造方法および該溶液を用いたAc-225標識錯体の製造方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07203974A (ja) 1994-01-13 1995-08-08 Tosoh Corp 癌特異的ムチンを認識する抗体の遺伝子断片等
JPH115749A (ja) 1997-06-13 1999-01-12 Tosoh Corp 癌治療医薬品組成物
US6670456B2 (en) * 2001-02-28 2003-12-30 Dow Global Technologies Inc. Actinium-225 complexes and conjugates for targeted radiotherapy
US7282567B2 (en) * 2002-06-14 2007-10-16 Immunomedics, Inc. Monoclonal antibody hPAM4
US7087206B2 (en) * 2002-04-12 2006-08-08 Pg Research Foundation Multicolumn selectivity inversion generator for production of high purity actinium for use in therapeutic nuclear medicine
DE10347459B3 (de) 2003-10-13 2005-05-25 Actinium Pharmaceuticals, Inc. Radium-Target sowie Verfahren zu seiner Herstellung
WO2005084179A2 (en) * 2003-12-01 2005-09-15 Immunomedics, Inc. Improved method for preparing conjugates of proteins and chelating agents
DE102006042191B4 (de) * 2005-09-09 2010-08-05 Actinium Pharmaceuticals, Inc. Verfahren zur Reinigung von Radium aus verschiedenen Quellen
DE102006008023B4 (de) * 2006-02-21 2008-05-29 Actinium Pharmaceuticals, Inc. Verfahren zum Reinigen von 225Ac aus bestrahlten 226Ra-Targets
CA2662932C (en) 2006-09-08 2017-06-06 Actinium Pharmaceuticals, Inc. Method for the purification of radium from different sources
WO2013157105A1 (ja) 2012-04-18 2013-10-24 公立大学法人大阪市立大学 ムチンサブタイプ5ac特異的ヒト化抗体およびその利用
WO2013157102A1 (ja) 2012-04-18 2013-10-24 公立大学法人大阪市立大学 ムチンサブタイプ5ac特異的ヒト化抗体およびその利用
DE102014115154A1 (de) * 2014-10-17 2016-04-21 SCV-SpezialChemikalien-Vertrieb GmbH Konjugierte Bisphosphonate für die Diagnostik und Therapie von Knochenerkrankungen
US10227383B2 (en) 2015-05-20 2019-03-12 Kagoshima University Specific modification of antibody with IgG-binding peptide
SG10202012408UA (en) 2016-06-13 2021-01-28 Univ Kagoshima SITE-SPECIFIC RADIOISOTOPE-LABELED ANTIBODY USING IgG-BINDING PEPTIDE
CN118430866A (zh) * 2017-06-29 2024-08-02 南非核能Soc有限公司 放射性同位素的制备
KR102533289B1 (ko) 2019-06-19 2023-05-17 니혼 메디피직스 가부시키가이샤 226Ra 타깃의 제조 방법, 225Ac의 제조 방법 및 226Ra 타깃 제조용 전착액
KR102490805B1 (ko) * 2019-07-02 2023-01-20 니혼 메디피직스 가부시키가이샤 226Ra 함유 용액의 정제 방법, 226Ra 타깃의 제조 방법, 및 225Ac의 제조 방법
KR20220047974A (ko) 2019-08-21 2022-04-19 니혼 메디피직스 가부시키가이샤 방사성 금속 착체의 제조 방법
PH12022550919A1 (en) 2019-10-18 2023-07-10 Nihon Mediphysics Co Ltd Method for producing radioactive metal-labeled antibody

Similar Documents

Publication Publication Date Title
JPWO2022149578A5 (https=)
Goeckeler et al. 153Sm radiotherapeutic bone agents
Rodrigue et al. Cyclotron production of^ sup 99m^ Tc: an approach to the medical isotope crisis
JP2022188190A5 (https=)
JP7515547B2 (ja) 226Ra含有溶液の精製方法、226Raターゲットの製造方法および225Acの製造方法
Reissig et al. The impact of barium isotopes in radiopharmacy and nuclear medicine–From past to presence
US12237092B2 (en) Purification process for the preparation of non-carrier added copper-64
US6309614B1 (en) Method for isolating and purifying 90Y From 90strontium in multi-curie quantities
A. Osso et al. Technetium-99m–new production and processing strategies to provide adequate levels for SPECT imaging
AU2001251607A1 (en) A method for isolating and purifying 90Y from 90strontium in multi-curie quantities
EP2301041A1 (en) A process for the production of no-carrier added 99mo
CA1243603A (en) Phosphonic acid complexes for the treatment of calcific tumors
US20190338394A1 (en) Process for the separation and purification of medical isotopes
CA1270845A (en) Aminocarboxylic acid complexes for the treatment of calcific tumors
JP6564961B1 (ja) 放射性ヨウ素標識15−(4−ヨードフェニル)−3(r,s)−メチルペンタデカン酸の製造方法
CN109437343B (zh) 一种高锝酸钠溶液的制备方法
EP0225409A1 (en) Organic amine phosphonic acid complexes for the treatment of calcific tumors
Lungu et al. Radiolabeled phosphonates for bone metastases therapy
Motaleb et al. Synthesis and evaluation of 99 m Tc-NIDA and 99 m Tc-DMIDA complexes for hepatobiliary imaging
CA1232914A (en) Radioactive metals complexed with derivatives of bicycloheptane bis (methylenes)
RU2332735C1 (ru) Способ получения радионуклида палладий-103 без носителя
EP1015419B1 (en) Polydentate imines and their metal complexes
Woolfenden et al. [153Sm] citrate for tumor and abscess localization
Zhang et al. Synthesis and biodistribution of a novel 99m Tc nitrido dithiocarbamate complex containing ether group as a potential myocardial and brain imaging agent
CA1254508A (en) Imaging cardiac infarcts with radioactive metals complexed with phosphonate derivatives of dicyclopentadienebis (methylamine)